AXGN Axogen, Inc.
Healthcare · Electromedical & Electrotherapeutic Apparatus
Axogen, Inc. (AXGN) is a healthcare company in the Electromedical & Electrotherapeutic Apparatus industry, with a market capitalization of $2.4 billion. Shares last traded at $44.91, 10.2% below their 52-week high. Over the past year the stock is up 372.2%. Net profit margin is -7.0%, in line with the peer median of -7.0%. Revenue grew 20.2% year over year.
Performance
Chart
Full chart →Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.
Technicals
Financials
Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.
Recent earnings
| Period | EPS (diluted) | Reported |
|---|---|---|
| Q1 2026 | $-0.38 | 2026-04-28 |
| FY 2025 | $-0.34 | 2026-02-24 |
| Q3 2025 | $-0.06 | 2025-10-29 |
| Q2 2025 | $-0.07 | 2025-08-05 |
| Q1 2026 | $-0.08 | 2026-04-28 |
| FY 2025 | $-0.23 | 2026-02-24 |
Electromedical & Electrotherapeutic Apparatus peers
AXGN vs 14 industry peers (Electromedical & Electrotherapeutic Apparatus), by market cap.
| MDT | Medtronic | $101.6B | 21.16 | 2.79 | 13.2% | +1.55% |
| LIVN | Livanova Plc | $4.3B | -17.78 | 3.11 | -17.5% | -0.04% |
| ITGR | Integer Holdings Corp | $3.1B | 30.03 | 1.67 | 5.5% | +1.47% |
| TMDX | Transmedics Group, Inc. | $2.7B | 14.31 | 4.50 | 31.4% | +7.63% |
| AXGN | Axogen, Inc. | $2.4B | -152.09 | 10.60 | -7.0% | -2.11% |
| BLFS | Biolife Solutions Inc | $1.3B | -276.77 | 13.22 | -4.8% | +2.00% |
| CNMD | Conmed Corp | $1.0B | 21.33 | 0.73 | 3.4% | +1.50% |
| CBLL | Ceribell, Inc. | $685M | — | — | — | +4.49% |
| CV | CapsoVision, Inc | $331M | — | — | — | +1.85% |
| ELMD | Electromed, Inc. | $315M | 41.86 | 4.93 | 11.8% | +2.20% |
| STXS | Stereotaxis, Inc. | $184M | -8.49 | 5.68 | -66.8% | +5.32% |
| HYPR | Hyperfine, Inc. | $154M | -4.34 | — | — | +13.26% |
| VANI | Vivani Medical, Inc. | $100M | 3.78 | — | — | +1.75% |
| STEX | Streamex Corp. | $95M | -0.20 | — | — | -2.54% |
Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.